System and method for treating biological vessels

Information

  • Patent Grant
  • 12144750
  • Patent Number
    12,144,750
  • Date Filed
    Friday, December 10, 2021
    2 years ago
  • Date Issued
    Tuesday, November 19, 2024
    3 days ago
Abstract
A system for performing angioplasty and a method of utilizing same are provided. The system includes a balloon mounted on a catheter shaft and an expandable constraining structure mounted over the balloon. The expandable constraining structure includes a plurality of axial struts crossing a plurality of radially-expandable rings being for constraining said balloon such that isolated balloon regions protrude through openings in said constraining structure when the balloon is inflated.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

The present invention relates to a system and method for treating biological vessels and, more particularly, to an angioplasty balloon catheter having an expandable constraining structure positioned over the balloon and configured for constraining balloon inflation thereby enabling isolated balloon regions to protrude from the constraining structure during inflation.


Description of the Related Art

Percutaneous transluminal angioplasty (PTA) is a procedure in which a balloon catheter is inserted through an artery and guided to the region of lumen narrowing. The balloon is inflated to force the plaque material (typically fat and calcium) against the wall of the artery to open the vessel lumen and improve blood flow.


Angioplasty balloons are typically cylindrical when inflated and have different lengths and diameters to conform to different vessel sizes. The balloons are inflated at high pressure, normally between 8-20 atmospheres, in order to overcome the resistance of the plaque and achieve luminal expansion.


High pressure angioplasty is often traumatic to the vessel walls and can lead to vessel wall dissections. Such dissections are common and can be severe and may require urgent surgery or placement of stents. In addition, dissection may contribute to poor long term clinical results and restenosis even if a stent is placed in the treated lesion.


Dissections are usually attributed to several mechanisms occurring during balloon inflation including shear forces applied on the vessel walls as the balloon pleats unfold as well as uneven balloon inflation which occurs as a result of the non-symmetric nature of the vascular disease.


Shear forces result from balloon unfolding and an increase in balloon diameter in the radial direction as the folded balloon unwraps. As the folded pleats of the balloon open, the layers slide over one another and apply tangential forces to the lesion and/or vessel wall which can abrade the lesion or vascular wall and in the worst instances cause dissections.


Uneven inflation results from the uneven nature of the disease in the vessel. Angioplasty balloons are commonly non-compliant or semi-compliant, and when semi-compliant balloons are inflated against an eccentric lesion, the balloon will follow the “path of least resistance” and its diameter will increase more in the less diseased sections of the vessel (causing a dog bone effect), often increasing trauma in these areas.


Due to the above limitations, standard balloon catheters are also incapable of applying local forces sufficient to open to resistant plaque regions and thus can be ineffective in providing ample patency in highly calcified lesions, such as those prevalent in peripheral arteries.


Attempts to solve the above limitations of balloon catheters by increasing local forces via cutting or scoring elements (blades/wires) positioned on the balloon surface (e.g. US20040143287 and US20060085025) were somewhat successful at opening resistant lesions but did not adequately solve the aforementioned problems resulting from balloon unfolding and uneven inflation.


Thus it would be highly advantageous to have an angioplasty balloon catheter configured for minimizing trauma and dissection to the blood vessel walls as the balloon is inflated as well as for enabling application of local forces to discrete lesion regions that are resistant to opening.


SUMMARY OF THE INVENTION

According to one aspect of the present invention, there is provided a system for performing angioplasty comprising: (a) a balloon mounted on a catheter shaft; and (b) an expandable constraining structure including a plurality of axial struts crossing a plurality of radially-expandable rings, for constraining the balloon such that isolated balloon regions protrude through openings in the constraining structure when the balloon is inflated; the expandable constraining structure being configured such that radial expansion of the radially-expandable rings does not substantially alter a distance between adjacent radially-expandable rings.


According to further features in preferred embodiments of the invention described below, the expandable constraining structure is also configured such that radial expansion of the radially-expandable rings moves adjacent axial struts attached to the adjacent radially-expandable rings in opposite (axial) directions.


According to still further features in the described preferred embodiments, the radially-expandable rings are configured with peaks and valleys forming an undulating omega loop path.


According to still further features in the described preferred embodiments, the plurality of axial struts interconnect the plurality of radially-expandable rings at the peaks and the valleys.


According to still further features in the described preferred embodiments, the system comprises at least 4 axial struts crossing at least 4 radially-expandable rings forming at least 16 of the openings.


According to still further features in the described preferred embodiments, the expandable constraining structure further includes first and second end rings for fixedly attaching the expandable constraining structure to the catheter.


According to still further features in the described preferred embodiments, the first and second rings are connected to terminal radially-expandable rings via N end struts, N being half of a number of the plurality of axial struts.


According to still further features in the described preferred embodiments, the N end struts of the first end ring are connected to peaks of a first terminal radially-expandable ring, and the N end struts of the second end ring are connected to valleys of a second terminal radially-expandable ring.


According to still further features in the described preferred embodiments, the N end struts of the first end ring are connected to peaks of a first terminal radially-expandable ring, and the N end struts of the second end ring are connected to peaks of a second terminal radially-expandable ring.


According to still further features in the described preferred embodiments, N may be 2 or 3 or 4.


According to still further features in the described preferred embodiments, the plurality of axial struts are fabricated from a super-elastic alloy having a thickness of from about 0.04 to about 0.12 mm.


According to still further features in the described preferred embodiments, the plurality of radially-expandable rings are fabricated from a super-elastic alloy having a thickness of about 0.05 to about 0.12 mm.


According to still further features in the described preferred embodiments, the plurality of radially-expandable rings are capable of radially expanding from a compressed state of about 1 mm to an expanded state of at least about 5 mm and in some embodiments about 6 mm in diameter, or from a compressed state of 2 mm to an expanded state of at least about 8 or 10 mm and in some embodiments 12 mm in diameter. In any case, the radially expandable rings have an expanded diameter which is smaller than that of the inflated balloon in order to enable the balloon to protrude through the constraining structure and form the pillow-like structures described herein.


According to still further features in the described preferred embodiments, the plurality of radially-expandable form an undulating radial path when compressed and a linear radial path when expanded.


According to still further features in the described preferred embodiments, a length of the expandable constraining structure from the first end ring to the second end ring is 10-300 mm.


According to still further features in the described preferred embodiments, each omega loop of the undulating omega loop path is composed of two contiguous sine curves.


According to still further features in the described preferred embodiments, the sine curve has a radius of 0.3-0.5 mm, such as at least about 0.35 mm or at least about 0.45 mm.


According to still further features in the described preferred embodiments, the isolated balloon regions protrude about 0.1-0.7 mm from the radially outwardly facing surface of the expandable constraining structure, such as at least about 0.3 mm, and preferably at least about 0.6 mm.


According to still further features in the described preferred embodiments, the balloon is coated with a drug coating, which may also contain an excipient or excipients. The excipient is an inactive substance that serves as the vehicle or medium for an active drug substance.


According to still further features in the described preferred embodiments, the drug coating is applied on the isolated balloon regions that protrude through the openings.


According to still further features in the described preferred embodiments, the isolated balloon regions protruding through the openings are rectangular.


According to still further features in the described preferred embodiments, the isolated balloon regions protruding through the openings are about 1-5 mm in length and 1-3.5 mm in width.


According to another aspect of the present invention, there is provided a method of treating a body vessel comprising: (a) positioning, in the vessel, a balloon disposed within an expandable constraining structure including a plurality of axial struts crossing a plurality of radially-expandable rings being for constraining the balloon such that isolated balloon regions protrude through openings in the expandable constraining structure when the balloon is inflated; the expandable constraining structure being configured such that radial expansion of the radially-expandable rings: (i) does not substantially alter a distance between adjacent radially-expandable rings; and (ii) axially moves adjacent axial struts attached to the adjacent radially-expandable rings in opposite directions; and (b) inflating the balloon so as to enable the isolated balloon regions to protrude through the openings and contact a wall of the vessel while the plurality of axial struts and the plurality of radially-expandable rings are displaced from the vessel, thereby treating the body vessel.


According to still further features in the described preferred embodiments, (b) is effected by inflating the balloon to at least 3 atm.


According to still further features in the described preferred embodiments, the vessel is an artery and the treatment is angioplasty.


According to another aspect of the present invention there is provided a medical prosthesis comprising a substantially tubular expandable structure including a plurality of axial struts crossing a plurality of radially-expandable rings, the expandable constraining structure being configured such that radial expansion of the radially-expandable rings: (a) does not substantially alter a distance between adjacent radially-expandable rings; and (b) axially moves adjacent axial struts attached to the adjacent radially-expandable rings in opposite directions.


The present invention successfully addresses the shortcomings of the presently known configurations by providing a balloon catheter that includes a cage-like constraining structure designed for minimizing dissection-inducing stresses on the vessel wall while enabling localized high pressure treatment of dilation-resistant lesion regions.


Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention is herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the preferred embodiments of the present invention only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.



FIGS. 1a-b illustrate one embodiment of the present system in a non-inflated configuration (FIG. 1a) and in an inflated configuration (FIG. 1b) showing protrusion of isolated balloon regions.



FIG. 2a is a drawing of one end of the constraining structure in a magnified view containing 2 rings and one end crown of the CS when the CS is not expanded by the balloon.



FIGS. 2b-d illustrate one end of the constraining structure while expanding from a collapsed state (FIG. 2b), through a partially expanded state (FIG. 2c) to a fully expanded state (FIG. 2d).



FIGS. 3a-c illustrate a CS having three end strut configurations that lead to: a decrease in CS length (FIG. 3a), an increase in CS length (FIG. 3b) or no change in CS length (FIG. 3c) when the CS is expanded.



FIGS. 4a-b schematically illustrate a ring loop having a small radius of curvature (FIG. 4a) and a ring having a loop with a relatively large radius of curvature (FIG. 4b).



FIGS. 5a-b illustrate strut buckling (FIG. 5a) and ring failure (FIG. 5b) in an experimental prototype.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

The present invention relates to a balloon catheter system which can be used to open stenosed vessel region while minimizing vessel wall trauma and dissections and providing localized forces to discrete lesion regions and a homogeneous distribution of forces along the lesion.


The principles and operation of the present invention may be better understood with reference to the drawings and accompanying descriptions.


Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details set forth in the following description or exemplified by the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein are for the purpose of description and should not be regarded as limiting.


Attempts to traverse the limitations of standard angioplasty balloon catheters using cutting or scoring elements have met with limited clinical success.


In a previously filed patent application (U.S. patent application Ser. No. 13/044,425, filed Mar. 9, 2011, the entire disclosure of which is hereby incorporated by reference), the present inventors described a balloon catheter that includes an expandable constraining structure (CS) positioned over an angioplasty balloon. The constraining structure was configured such that when the balloon was inflated to a diameter larger than that of the expandable constraining structure, isolated balloon regions protruded from openings in the expandable constraining structure. Such a unique configuration protected the vessel wall from the effects of balloon unfolding and uneven inflation while also enabled application of localized forces to a discrete plaque region.


In order to enable a delivery state and expansion in the vessel (and enable isolated balloon regions to protrude therethrough), the expandable constraining structure of U.S. patent application Ser. No. 13/044,425 is preferably constructed from several axial struts crossing several radially-expandable rings (forming a cage with balloon openings). The radially expandable rings must be compressed for delivery and expanded for operability and should preferably assume a linear circumferential configuration when expanded such that isolated balloon regions protruding through the expandable constraining structure contact substantially linear surfaces.


Thus, the operability of the expandable constraining structure, and in particular its ability to compress and expand without applying excessive strain to its structural elements and upon the balloon, largely depends on the radially expandable rings and connection therebetween.


Expansion through large diameter ranges can strain the struts and rings, leading to ring failure or strut deformation (see Example section).


Thus, the present inventors continued to experiment with various expandable constraining structure designs, and particularly with various radially expandable rings designs, in efforts to improve the operability of the expandable constraining structure.


As is described hereunder and in the Examples section which follows, the present inventors have devised a radially expandable ring configuration that substantially enhances the operability of the expandable constraining structure.


Thus, according to one aspect of the present invention there is provided a system for performing angioplasty in a subject (e.g. a human subject).


The system includes a balloon mounted on a catheter shaft and an expandable constraining structure mounted over the balloon (in a coaxial arrangement), and fixedly attached at its distal and proximal ends to the catheter shaft.


The catheter can be any catheter configuration suitable for use in angioplasty procedures. The catheter can be configured for over-the-wire or a rapid exchange delivery and can include suitable connectors for wire insertion, inflation and the like at its proximal end. The catheter shaft can be any length and diameter suitable for angioplasty of peripheral, coronary or cerebral blood vessels. Suitable lengths (L) and diameters (D) can be in the range of about 5-30 mm L, 2-5 mm D for coronary applications and 20-300 mm L, 2-12 (or more) mm D for peripheral vessels applications.


The balloon can be a compliant, a semi-compliant or a non-complaint balloon fabricated from nylon, Pebax and the like at dimensions selected from a range of about 5-300 mm in length and about 2-12 (or more) mm in diameter. The balloon can be cylindrical, or any other shape known in the art.


The expandable constraining structure includes a plurality of axial struts crossing a plurality of radially-expandable rings. The struts and rings form a cage-like structure that expands with balloon expansion, but constrains the balloon such that isolated balloon regions protrude through openings in the cage structure when the balloon is inflated therein.


Thus, the expandable constraining structure provides protection of vessel wall/plaque from shear forces caused by balloon unfolding, protection from uneven expansion during radial dilatation, and strain relief zones through isolated balloon protrusions.


The expandable constraining structure is configured such that radial expansion of the radially-expandable rings does not substantially alter a distance between any two axially adjacent rings while shifting circumferentially-adjacent axial struts (interconnecting the two adjacent rings) in opposite directions (e.g., one strut shifts in a proximal direction, while its circumferentially-adjacent strut shifts in a distal direction).


Such an expansion profile can provide several advantages:

    • (i) the radially expandable rings do not substantially shift axially with respect to the balloon and thus do not apply frictional forces thereto during inflation;
    • (ii) such an expandable constraining structure can be configured such that its length increases, decreases or remains constant during expansion; since balloons can also change during inflation, such a feature can further reduce strain on the expandable constraining structure and/or balloon; and
    • (iii) expandable constraining structure can match changes in length of the balloon during inflation, thus enabling fixedly attaching the CS to the catheter shaft on both sides of the balloon without a need for length compensation design elements.



FIGS. 1a-3c illustrate angioplasty systems that include expandable constraining structures constructed in accordance with the teachings of the present invention.


Referring now to the drawings, FIGS. 1a-b illustrate one embodiment of an angioplasty system which is referred to herein as system 10. FIG. 1a illustrates a system 10 in a collapsed (delivery) configuration, while FIG. 1b illustrates system 10 in an expanded configuration.


System 10 includes a catheter 12 having a shaft 14 which is fabricated from one or more concentrically arranged hollow tubes (typically 3) fabricated from a polymer such as Nylon, Pebax, HDPE, LDPE, PTFE, Polyimide and the like. A balloon 16 is mounted on a distal end region 18 of shaft 14 and is inflatable via an inflation lumen that extends the length of shaft 14 from balloon 16 to a handle/connector (not shown) of system 10 mounted on the proximal end of shaft 14. Balloon 16 is fabricated and bonded onto shaft 14 using well known prior art approaches.


An expandable constraining structure 20 (referred to hereunder as CS 20, a portion of which is shown separately in FIG. 2a) which is tubular in shape is mounted over balloon 16 in a co-axial arrangement. CS 20 is fixedly attached with respect to shaft 14 via two end rings 22, each being connected to a terminal radially expandable ring 24 (proximal ring—26, distal ring—28) of CS 20 via one or more end struts 30. The region of CS 20 encapsulating balloon 16 includes a plurality of axial struts 32 [also referred to herein as strut(s) 32] crossing a plurality of radially expandable rings 24 [also referred to herein as ring(s) 24]. Rings 24 and struts 32 form a grid with opening 34 through which isolated balloon region 36 protrude (0.2-0.7 mm above the surface of CS 20) upon inflation of the balloon to a pressure of 2-3 atmospheres or more and form pillow like structures 37 of 0.2-3.5 mm (preferably 1-3 mm) in length and width (FIG. 1b) with rings 24 and struts 32 forming depressions therebetween. Such pillow-like structures 37 are formed upon inflation since CS 20 expands to a diameter which is less than the diameter of the inflated balloon 16.


CS 20 can be fabricated from welded superelastic wire (having a round or rectangular profile), or it can be laser cut from a tube/sheet. Rings 24 and struts 32 can be fabricated from a superelastic alloy such as Nitinol and have a thickness of 0.04 to 0.12 mm (indicated by TR and TS in FIG. 2a).


Any number of rings 24/struts 32 can be used in CS 20. For example, CS 20 can include a number of rings 24, e.g. 4-80 and 2-6 struts 32. The number of rings 24 can be determined by the balloon length divided by two or three. Forty rings 24 and 4 struts 32 are shown in FIGS. 1a-b for an 80 mm length balloon. The number of rings 24, and to a lesser degree struts 32 used in CS 20, can depend on the application (type of vessel) and diameter of vessel treated, and the length of balloon 16 used. For example, in peripheral angioplasty, system 10 can utilize a balloon having a diameter of 3.0 mm and length of 80 mm and, as such, can include a CS 20 having 4 struts 32 and about 40 rings 24, resulting in 156 openings 34. Generally a CS 20 having 8-400 openings 34 can be formed, such as at least about 50, in some embodiments at least about 100 or 200. When used in angioplasty, the length of isolated balloon regions 36 is preferably selected so as to enable application of an inflation force to discrete stenosed regions 5-30 mm in length and 2.0-12.0 mm in diameter. Thus, in such cases, the length of balloon 16 dictates the number of rings 24. The CS will typically create at least about 1, at least about 1.5 and in some implementations at least about 1.75 pillows in the inflated balloon per 1 mm of inflated balloon, length, depending upon desired clinical performance.


As is mentioned hereinabove rings 24 have a unique structure and unique strut 32 interconnections.



FIG. 2a is a magnified flat view of 2 rings 24 (proximal terminal ring 26 and adjacent ring 40) and portions of 4 struts 32 that interconnect rings 24 when CS is collapsed (for delivery). Since CS 20 is a cylinder, it is flattened for the purpose of illustration by separating strut 32 into halves 44 and 46. FIG. 2a also shows end ring 22 (having a width of about 0.25-1.5 mm, indicated by RW in FIG. 2a) which is connected to ring 26 through angled couplers 31 (three triangular-shaped couplers shown) and three end struts 30 (one end strut 30 separated into halves 48 and 50). The width of end ring 22 and attached couplers 31 can be about 1.5-6 mm (indicated by EW in FIG. 2a).


In the collapsed configuration, rings 24 are preferably configured with peaks 52 and valleys 54 (peaks 52 face left in the Figures) forming an undulating omega loop 56 (one omega loop 56 emphasized in FIG. 2a) path. Peaks 52 and valleys 54 are curved to facilitate linearization of omega loops 56 during expansion of CS 20. The path between peak 52 and valley 54 of two contiguous omega loops 56 forms a sine wave/curve.


Expansion of ring 24 nearly linearizes each sine curve. Therefore the sine radius has to be large enough in order not to develop high strains in ring 24 and fail. The preferred sine radius is about 0.3-0.5 mm. The overall length of the sine path (darkened line referenced by LS in FIG. 2a) is smaller than the circumference of inflated balloon 16. For example for a 3 mm diameter balloon the circumference is 3×π and the sine length is 2.8×π. This length is determined by the strains that form in ring 24 upon inflation (these strains increase with shorter sign length). This sine length is also small enough to form pillow-like structures 37 (between about 0.2 to 0.5 mm in height beyond the radially outwardly facing surface of the adjacent CS). These two parameters (sine length and sine radius) dictate the sine amplitude, in this example (for 3 mm balloon) about 1.4 mm, and also dictate a minimum for the distance between adjacent rings 24. FIGS. 2b-d illustrate expansion of CS 20 showing linearization of rings 24 and struts 32 (to final shape in FIG. 2d) while maintaining distances between adjacent rings 24 and struts 32 substantially unchanged.


Any number of omega loops (e.g., one or two or three or four or more) can be included in ring 24. However, in cases where rings 24 need to tightly fit over a folded balloon 16 in order to accommodate delivery thru tight lesions, the relatively large sine radius and small overall diameter of compressed ring 24 can dictate two sine waves per ring 24 (two peaks 52 and two valleys 54) in a balloon less than 4.5 mm (inflated diameter). A balloon 4.5 mm or larger (inflated diameter) can accommodate three sine waves per ring 24 (three peaks 52 and thereto valleys 54) and can be compressed for delivery to about 1 mm or slightly more (e.g. 1.2 mm).


Struts 32 (four in FIG. 2a) interconnect rings through peaks 52 and valleys 54 (peak-to-peak, valley-to-valley). Struts 32 can follow a linear or slightly undulating path along the length of CS 20. The latter is preferred since rings 24 are more efficiently packed (lengthwise) by circumferentially offsetting peak 52/valleys 54 of adjacent rings 24.


An undulating path (for strut 32) can also be advantageous due to deformation of strut 32 upon expansion of CS 20. The ends of strut 32 are attached to the rings 24 and therefore are forced to the relatively small diameter of the rings 24 on expansion. At the same time, the middle area of strut 32 is being pushed outwardly by the pressure of balloon 16, and thus, strut 32 arcs radially outward. A linear strut 32 would thus shorten upon expansion due to arcing. Such shortening between adjacent rings 24 can then result in shortening of the overall length of CS 20 and generation of high axial compression forces on the balloon. The undulating path of strut 32 mitigates this shortening: as pillows are formed on both sides of strut 32 they apply a force to strut 32 that linearize the strut and mitigates shortening. The magnitude of undulation can control the magnitude of shortening mitigation and can be selected such that the shortening is minimal and distance between rings is kept substantially constant.


As is shown in FIGS. 2b-c, when CS 20 expands (during balloon inflation), peaks 52 and valleys 54 linearize, thereby linearizing omega loops 56 from about 0 degrees to about 180 degrees to form a substantially linear ring 24 (FIG. 2c).


During expansion, adjacent struts 24 (60 and 62 in FIGS. 2a-c) shift in opposite axial directions; this is due to the fact that peaks 52 move in a direction opposite to valleys 54.


As is mentioned hereinabove, CS 20 is attached to catheter shaft 14 either directly, or to the balloon neck overlying the shaft, via two end rings 22 each connected via one or more end struts 30 to a terminal ring 24 (designated 26 and 28). End rings can be connected directly to end struts 30 or through a pair of angled couplers 31 (FIG. 2a). Use of such couplers 31 enables use of shorter end struts 30 thus making these relatively long and thin struts more stable.


The number of end struts 30 (on each side) can be half that of the number of struts 32. For example, in a CS 20 having 4 struts 32 (and any number of rings 24), an end ring 22 is connected to a terminal ring 24 (26 or 28) via 2 struts 30.


End rings 22 can be fixedly attached to shaft 14 preferably via thermal bonding crimping and/or adhesive bonding. End rings 22 are configured as zigzag rings with an amplitude of approximately 1 mm or shorter. End rings 22 are preferably connected via one or more struts 30 to external peaks 52 of terminal ring (26 or 28) although other connection configurations are also contemplated herein.


Since inflation of balloon 16 causes terminal rings 26 and 28 to expand and peaks 52 to linearize, connecting struts 30 (on both sides of CS 20) to a peak 52 of terminal ring 26 and a peak 52 of terminal ring 28 (which is on the same strut 32) can cause buckling (inward or outward arcing) of CS 20 and, as such, it is less preferred. To avoid such buckling, end rings 22 are preferably connected via strut 30 to a peak 52 of one terminal ring (e.g. 26) and a valley 54 of the opposite terminal ring (e.g. 28) in such a configuration that the connection does not span the same lengthwise strut 32.



FIGS. 3a-c illustrate a CS 20 which has 3 different end ring 22-strut 30-terminal ring 26 and end ring 22-strut 30-terminal ring 28 configurations which follow the above alternating peak 52-valley 54 connection. As is further described hereinunder, each configuration provides CS 20 with unique expansion properties.


In FIG. 3a, the left side end ring 22 is connected via two struts 30 to two peaks 52, while the right side end ring 22 is connected via two struts 30 to two valleys 54 (which are offset from peaks 52 and thus are not on the same lengthwise strut 32). In such a configuration, CS 20 will want to shorten by approximately one sine amplitude when expanded by the balloon and as such, CS 20 will track with balloon expansion (balloon also shortens during expansion due to formation of pillows on its surface).


In FIG. 3b, the left side end ring 22 is connected via two struts 30 to two valleys 54, while the right side end ring 22 is connected via two struts 30 to two peaks 52 (which are offset from peaks 52 and thus are not on the same lengthwise strut 32). In such a configuration, CS 20 will want to lengthen by approximately one sine amplitude upon expansion by the balloon however since it cannot lengthen (it is fixed to catheter shaft) CS 20 will buckle at the terminal struts/rings.


In FIG. 3c, the left side end ring 22 is connected via two struts 30 to two peaks 52, while the right side end ring 22 is connected via two struts 30 to two peaks 52 (which are on the same lengthwise strut 32). In such a configuration, CS 20 will maintain the same length upon expansion and as such it might buckle at the terminal struts/rings (see the Examples section for further detail).


System 10 can be fabricated using conventional balloon catheter components, such as metallic hypotube and/or polymer tubes for fabrication of the catheter shaft, an inflation hub at the proximal end, a polymeric guide wire lumen adapted to receive the guide wire, and an inflatable balloon 16 at its distal end. The balloon catheter components are attached to each other using techniques that are known in the art such as thermal bonding and adhesives.


CS 20 is preferably fabricated using laser cutting technique in which the CS pattern is cut from a Nitinol tube. CS 20 can then be electropolished and heat treated to form an inner diameter smaller than that of the folded balloon. CS 20 is mounted over balloon 16 and positioned relatively to the balloon such that rings 24 are positioned over the working length of balloon 16 (balloon cylindrical section in between the balloon tapers) and end rings 22 are positioned over the catheter shaft or balloon legs on both sides of balloon 16. End rings 22 are thermally bonded to the catheter shaft or the balloon legs.


System 20 can be used in angioplasty as follows. System 20 can be guided to the stenosed region over a guide-wire (not shown) using well known angioplasty approaches. Once in position, balloon 16 can be inflated to a point where it protrudes through CS 20 such that isolated regions of balloon 16 apply an outward radial force to the plaque. Once the region is sufficiently dilated, balloon 16 is deflated (thereby allowing the CS 20 to recover its set configuration) and system 20 is removed from the body.


Thus, the present invention provides an angioplasty system which protects the vessel wall from the shear forces caused by balloon unwrapping and radial and uneven expansion, as well as enables provision of localized higher pressure forces to specific lesion regions which are resistant, such as highly calcified expansion-resistant plaque regions.


Balloon 16 of system 20 or pillow-like regions thereof can be coated with a hydrophilic or hydrophobic coating to enhance lubricity. Alternatively, balloon 16 of system 20 or pillow-like regions thereof can be coated with a drug coating containing an antiproliferative drug such as sirolimus or paclitaxel using methods well known in the art.


As used herein the term “about” refers to ±10%.


Additional objects, advantages, and novel features of the present invention will become apparent to one ordinarily skilled in the art upon examination of the following examples, which are not intended to be limiting.


EXAMPLES

Reference is now made to the following examples, which together with the above descriptions, illustrate the invention in a non limiting fashion.


Prototype Testing


Several designs having different shaped rings and end strut attachment configurations were fabricated and tested.


Such testing demonstrated that the shape of the ring loop is critical for achieving expansion of balloon and constraining structure and balloon constraint without ring failure and that the end strut configuration (three types shown in FIGS. 3a-c) is crucial for limiting the stress on the end struts during expansion of the constraining structure (CS).



FIGS. 4a-b illustrate two types of ring loops, one having a small radius of curvature (top loop, FIG. 4a), and the other having a relatively large radius of curvature (top loop FIG. 4b). The ring loop of FIG. 4a has a radius of 0.2 mm resulting in a loop length of approximately 0.5 mm. The ring loop of FIG. 4b has a radius of 0.5 mm, resulting in a loop length of approximately 1.5 mm.


When a ring of CS 20 expands (under balloon inflation), the radii of the peaks and valleys (formed by the zigzagging loops) grow and stresses and strains form along the radius length maximizing at the peak/valley centers.


Since the loop of FIG. 4a needs to transition from a small radius to a linear structure, the strains that developed therein will be much larger than the strains on the loop of FIG. 4b which starts off having a larger radius (3×). As is shown in FIG. 5, a prototype having ring loops similar to those of FIG. 4a failed at relatively low inflation pressures (12 atm) while a prototype having loops similar to those of FIG. 4b was inflated to a pressure above 12 atm without any ring failure.


Testing of several prototypes also revealed that an end strut configuration of CS is important for maintaining CS integrity during inflation. FIG. 5a illustrates a CS having a strut configuration similar to that of FIG. 3c. As is clearly shown in this Figure, inflation of the balloon and expansion of the CS leads to buckling of the end struts (similar behavior was observed for CS having the strut configuration of FIG. 3b). In contrast, a CS having a strut configuration similar to that of FIG. 3a (CS will shorten during inflation) maintained strut-ring integrity during inflation and provided the best results.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.


Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.

Claims
  • 1. A system for performing angioplasty comprising: a balloon mounted on a catheter shaft and having a longitudinal axis; andan expandable constraining structure mounted over the balloon, the expandable constraining structure comprising: a plurality of axial struts crossing a plurality of rings configured for constraining the balloon such that isolated balloon regions protrude through openings in the expandable constraining structure when the balloon is inflated; anda first end ring and a second end ring for fixedly attaching the expandable constraining structure to the catheter shaft;wherein radial expansion of the plurality of rings axially moves adjacent axial struts of the plurality of axial struts in opposite directions;wherein each of the plurality of rings comprises peaks and valleys forming an undulating path;wherein each peak or valley forms a loop having a radius of about 0.38 mm to about 0.5 mm.
  • 2. The system of claim 1, wherein the plurality of axial struts interconnect the plurality of rings at the peaks and the valleys.
  • 3. The system of claim 1, wherein the plurality of rings linearize when expanded.
  • 4. The system of claim 1, wherein each of the first end ring and the second end ring are connected to a corresponding terminal ring of the plurality of rings by one or more end struts.
  • 5. The system of claim 4, wherein the one or more end struts are connected to peaks of one terminal ring and valleys of the other terminal ring.
  • 6. The system of claim 4, wherein the one or more end struts is N end struts, N being half of a number of the plurality of axial struts.
  • 7. The system of claim 1, wherein an overall length of the undulating path is smaller than a circumference of the balloon when inflated.
  • 8. The system of claim 1, wherein peaks of adjacent rings of the plurality of rings are circumferentially offset.
  • 9. The system of claim 1, wherein prior to inflation, the balloon is folded beneath the expandable constraining structure.
  • 10. The system of claim 1, wherein the isolated balloon regions protrude about 0.2 mm to about 0.5 mm in height beyond a radially outward facing surface of the expandable constraining structure.
  • 11. The system of claim 1, wherein the expandable constraining structure comprises Nitinol.
  • 12. The system of claim 1, wherein the balloon is coated with a drug.
  • 13. The system of claim 12, wherein the drug is coated on the isolated balloon regions that protrude through the openings.
  • 14. A method of performing angioplasty, the method comprising: advancing a balloon catheter into a blood vessel, the balloon catheter comprising a balloon disposed within a constraining structure including a plurality of axial struts crossing a plurality of rings, wherein each of the plurality of rings comprises peaks and valleys forming an undulating path, wherein each peak or valley forms a loop having a radius of about 0.38 mm to about 0.5 mm;expanding the constraining structure by inflating the balloon, wherein expanding the constraining structure axially moves adjacent axial struts in opposite directions; andfurther inflating the balloon to enable isolated balloon regions to protrude through openings in the constraining structure and contact a wall of the blood vessel while the plurality of axial struts and the plurality of rings are displaced from the blood vessel.
  • 15. The method of claim 14, further comprising deflating the balloon and allowing the constraining structure to recover to a collapsed configuration.
  • 16. The method of claim 14, wherein inflating the balloon causes the balloon to unfold.
  • 17. The method of claim 14, wherein further inflating the balloon enables the isolated balloon regions to protrude about 0.2 mm to about 0.5 mm in height beyond a radially outward facing surface of the constraining structure.
  • 18. The method of claim 14, wherein expanding the constraining structure linearizes an undulating path of each of the plurality of rings.
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This is a continuation of U.S. patent application Ser. No. 14/974,348, filed Dec. 18, 2015, which is a continuation of U.S. patent application Ser. No. 13/972,761, filed Aug. 21, 2013, now U.S. Pat. No. 9,216,033, which is a continuation-in-part of U.S. patent application Ser. No. 13/761,525, now U.S. Pat. No. 9,179,936, filed on Feb. 7, 2013, which claims the benefit of U.S. Provisional Application No. 61/596,618, filed Feb. 8, 2012, the entireties of both of which are incorporated by reference herein.

US Referenced Citations (196)
Number Name Date Kind
2701559 Cooper Feb 1955 A
2854983 Baskin Oct 1958 A
3045677 Wallace Jul 1962 A
3467101 Fogarty et al. Sep 1969 A
3825013 Craven Jul 1974 A
4327736 Inoue May 1982 A
4456011 Warnecke Jun 1984 A
4483340 Fogarty et al. Nov 1984 A
4637396 Cook Jan 1987 A
4723549 Wholey et al. Feb 1988 A
4796629 Grayzel Jan 1989 A
4921484 Hillstead May 1990 A
4976711 Parins et al. Dec 1990 A
4998539 Delsanti Mar 1991 A
5071407 Porter et al. Dec 1991 A
5100386 Inoue Mar 1992 A
5133732 Wilkor Jul 1992 A
5176693 Pannek Jan 1993 A
5181911 Shturman Jan 1993 A
5190058 Jones et al. Mar 1993 A
5196024 Barath Mar 1993 A
5222971 Willard et al. Jun 1993 A
5224945 Pannek, Jr. Jul 1993 A
5263963 Garrison et al. Nov 1993 A
5308356 Blackshear, Jr. et al. May 1994 A
5320634 Vigil et al. Jun 1994 A
5336178 Kaplan Aug 1994 A
5336234 Vigil et al. Aug 1994 A
5344419 Spears Sep 1994 A
5449372 Schmaltz et al. Sep 1995 A
5456666 Campbell et al. Oct 1995 A
5456667 Ham et al. Oct 1995 A
5460607 Miyata et al. Oct 1995 A
5484411 Inderbitzen et al. Jan 1996 A
5501694 Ressemann et al. Mar 1996 A
5527282 Segal Jun 1996 A
5556408 Farhat Sep 1996 A
5562620 Klein et al. Oct 1996 A
5571086 Kaplan et al. Nov 1996 A
5607442 Fischell et al. Mar 1997 A
5609574 Kaplan et al. Mar 1997 A
5616149 Barath Apr 1997 A
5620457 Pinchasik et al. Apr 1997 A
5628746 Clayman May 1997 A
5628755 Heller et al. May 1997 A
5643210 Lacob Jul 1997 A
5643312 Fischell et al. Jul 1997 A
5695469 Segal Dec 1997 A
5702410 Klunder et al. Dec 1997 A
5713863 Vigil et al. Feb 1998 A
5730698 Fischell et al. Mar 1998 A
5733303 Israel et al. Mar 1998 A
5735816 Lieber et al. Apr 1998 A
5755781 Jayaraman May 1998 A
5772681 Leoni Jun 1998 A
5776181 Lee et al. Jul 1998 A
5797935 Barath Aug 1998 A
5810767 Klein Sep 1998 A
5827321 Roubin et al. Oct 1998 A
5863284 Klein Jan 1999 A
5868708 Hart et al. Feb 1999 A
5868719 Tsukernik Feb 1999 A
5868779 Ruiz Feb 1999 A
5868783 Tower Feb 1999 A
5869284 Cao et al. Feb 1999 A
5904679 Clayman May 1999 A
5906639 Rudnick et al. May 1999 A
5919200 Stambaugh et al. Jul 1999 A
5961490 Adams Oct 1999 A
5967984 Chu et al. Oct 1999 A
5987661 Peterson Nov 1999 A
6013055 Bampos et al. Jan 2000 A
6036689 Tu et al. Mar 2000 A
6036708 Sciver Mar 2000 A
6053913 Tu et al. Apr 2000 A
6056767 Boussignac May 2000 A
6059810 Brown et al. May 2000 A
6059811 Pinchasik et al. May 2000 A
6077298 Tu et al. Jun 2000 A
6102904 Vigil et al. Aug 2000 A
6106548 Roubin et al. Aug 2000 A
6129706 Janacek Oct 2000 A
6156265 Sugimoto Dec 2000 A
6190403 Fischell et al. Feb 2001 B1
6206910 Berry et al. Mar 2001 B1
6217608 Penn et al. Apr 2001 B1
6235043 Reiley et al. May 2001 B1
6241762 Shanley Jun 2001 B1
6245040 Inderbitzen et al. Jun 2001 B1
6258099 Mareiro et al. Jul 2001 B1
6261319 Kveen et al. Jul 2001 B1
6309414 Rolando et al. Oct 2001 B1
6319251 Tu et al. Nov 2001 B1
6334871 Dor et al. Jan 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6416539 Hassdenteufel Jul 2002 B1
6454775 Demarais et al. Sep 2002 B1
6540722 Boyle et al. Apr 2003 B1
6605107 Klein Aug 2003 B1
6616678 Nishtala et al. Sep 2003 B2
6626861 Hart et al. Sep 2003 B1
6652548 Evans et al. Nov 2003 B2
6656351 Boyle Dec 2003 B2
6695813 Boyle et al. Feb 2004 B1
6702834 Boylan et al. Mar 2004 B1
6939320 Lennox Sep 2005 B2
6942680 Grayzel et al. Sep 2005 B2
7156869 Pacetti Jan 2007 B1
7186237 Meyer et al. Mar 2007 B2
7357813 Burgermeister Apr 2008 B2
7686824 Konstantino et al. Mar 2010 B2
7691119 Farnan Apr 2010 B2
7708748 Weisenburgh, II et al. May 2010 B2
7753907 DiMatteo et al. Jul 2010 B2
7803149 Bates et al. Sep 2010 B2
7931663 Farnan et al. Apr 2011 B2
8172793 Bates et al. May 2012 B2
8257305 Speck et al. Sep 2012 B2
8348987 Eaton Jan 2013 B2
8388573 Cox Mar 2013 B1
8439868 Speck et al. May 2013 B2
9179936 Feld et al. Nov 2015 B2
9199066 Konstantino et al. Dec 2015 B2
9216033 Feld et al. Dec 2015 B2
9375328 Farnan Jun 2016 B2
9415140 Speck Aug 2016 B2
9649476 Speck et al. May 2017 B2
10220193 Feld et al. Mar 2019 B2
10232148 Konstantino et al. Mar 2019 B2
10524825 Feld et al. Jan 2020 B2
10549077 Konstantino et al. Feb 2020 B2
11000680 Konstantino et al. May 2021 B2
11234843 Feld et al. Feb 2022 B2
20020010489 Grayzel et al. Jan 2002 A1
20030014100 Maria Meens Jan 2003 A1
20030023200 Barbut et al. Jan 2003 A1
20030040790 Furst Feb 2003 A1
20030065354 Boyle Apr 2003 A1
20030078606 Lafontaine et al. Apr 2003 A1
20030114915 Mareiro et al. Jun 2003 A1
20030114921 Yoon Jun 2003 A1
20030120303 Boyle et al. Jun 2003 A1
20030144726 Majercak et al. Jul 2003 A1
20030153870 Meyer et al. Aug 2003 A1
20030195609 Berenstein et al. Oct 2003 A1
20030212449 Cox Nov 2003 A1
20040034384 Fukaya Feb 2004 A1
20040073284 Bates et al. Apr 2004 A1
20040143287 Konstantino et al. Jul 2004 A1
20040210235 Deshmukh Oct 2004 A1
20040210299 Rogers et al. Oct 2004 A1
20040230293 Yip et al. Nov 2004 A1
20050021071 Konstantino et al. Jan 2005 A1
20050021130 Kveen et al. Jan 2005 A1
20050049677 Farnan Mar 2005 A1
20050125053 Yachia et al. Jun 2005 A1
20050271844 Mapes et al. Dec 2005 A1
20060008606 Horn et al. Jan 2006 A1
20060015133 Grayzel et al. Jan 2006 A1
20060085025 Farnan et al. Apr 2006 A1
20060085058 Rosenthal et al. Apr 2006 A1
20060149308 Melsheimer et al. Jul 2006 A1
20060259005 Konstantino et al. Nov 2006 A1
20060271093 Holman et al. Nov 2006 A1
20070073376 Krolik et al. Mar 2007 A1
20070173923 Savage et al. Jul 2007 A1
20080255508 Wang Oct 2008 A1
20090036964 Heringes et al. Feb 2009 A1
20090038752 Weng et al. Feb 2009 A1
20090105686 Snow et al. Apr 2009 A1
20090192453 Wesselman Jul 2009 A1
20090227949 Knapp et al. Sep 2009 A1
20090240270 Schneider et al. Sep 2009 A1
20090319023 Hildebrand et al. Dec 2009 A1
20100042121 Schnieder et al. Feb 2010 A1
20100234875 Allex et al. Sep 2010 A1
20100241215 Hansen et al. Sep 2010 A1
20100331809 Sandhu et al. Dec 2010 A1
20110066225 Trollsas et al. Mar 2011 A1
20110071616 Clarke et al. Mar 2011 A1
20110172698 Davies et al. Jul 2011 A1
20120059401 Konstantino et al. Mar 2012 A1
20120083733 Chappa Apr 2012 A1
20120245607 Gershony et al. Sep 2012 A1
20130046237 Speck et al. Feb 2013 A1
20130116655 Bacino et al. May 2013 A1
20130190725 Pacetti et al. Jul 2013 A1
20130211381 Feld Aug 2013 A1
20140276406 Campbell et al. Sep 2014 A1
20150209556 Timothy Jul 2015 A1
20160100964 Feld et al. Apr 2016 A1
20190151627 Konstantino et al. May 2019 A1
20190151631 Feld et al. May 2019 A1
20200139093 Feld et al. May 2020 A1
20200215311 Konstantino et al. Jul 2020 A1
20210128891 Konstantino et al. May 2021 A1
Foreign Referenced Citations (18)
Number Date Country
1568165 Jan 2005 CN
0 565 796 Oct 1993 EP
0 623 315 Nov 1994 EP
0 832 608 Apr 1998 EP
1 042 997 Oct 2000 EP
2 035 291 Mar 2009 EP
2005-508709 Apr 2005 JP
2014-528809 Oct 2014 JP
WO 9805377 Feb 1998 WO
WO 9850101 Nov 1998 WO
WO 0057815 Oct 2000 WO
WO 2002068011 Sep 2002 WO
WO 2003041760 May 2003 WO
WO 2005020855 Mar 2005 WO
WO 2011112863 Sep 2011 WO
WO 2013066566 May 2013 WO
WO 2013114201 Aug 2013 WO
WO 2013119735 Aug 2013 WO
Non-Patent Literature Citations (6)
Entry
AngioSculpt XL PT Scoring Balloon Catheter Brochure, AngioScore, Inc., Rev. C, May 2013.
Bearing Works, (PTFE) Polytetrafluoroethylene material specifications sheet, available online Feb. 11, 2018 at https://www.bearingworks.com/uploaded-assets/pdfs/retainers/ptfe-datasheet.pdf; printed Feb. 21, 2018, in 2 pages.
Brydson, J.A., “Plastics Materials—Sixth Edition,” 1995, p. 510, available in part online from https://books.google.com/books?id=wmohBQAAQBAJ&lpg=PA510&ots=G_4Q-OMpB4&dq=young's%20modulus%20of%20PEBAx&pg=PA510#v=onepage&q=young's%20modulus%20of%20PEBAx&f=false; printed on May 5, 2017.
Kadish, A., et al. “Mapping of Atrial Activation With a Noncontact, Multielectrode Catheter in Dogs,” Circulation: Journal of the American Heart Association, (Apr. 1999) 99: 1906-1913.
International Search Report for Appl. No. PCT/US13/25032, mailed Apr. 19, 2013 in 8 pages.
“Materials Data Book,” Cambridge University Engineering Department, 2003, pp. 1-41.
Related Publications (1)
Number Date Country
20220168120 A1 Jun 2022 US
Continuations (2)
Number Date Country
Parent 14974348 Dec 2015 US
Child 17643674 US
Parent 13972761 Aug 2013 US
Child 14974348 US